SIAVASH GHAZI: Open Payments
NPI 1689026007 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 32 payments from 8 companies in 2025. Trend: 2023 $547 · 2024 $946 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $222 |
| Neurocrine BioSciences, Inc. | 8 | $208 |
| E.R. Squibb & Sons, L.L.C. | 5 | $148 |
| Lundbeck LLC | 3 | $96 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Alkermes, Inc. | 2 | $48 |
| ABBVIE INC. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: INVEGA SUSTENNA, INGREZZA, COBENFY, ABILIFY ASIMTUFII, ABILIFY MAINTENA, ARISTADA, VRAYLAR, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
